What the company does
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, …
What the weekly tape is saying
MRK closed the latest completed week at 35,340 ARS. The 4-week return is 7.0% and the 12-week return is 5.7%. Trend Signal is active, Market Dynamics is -0.22. Setup signature: Balanced read with a 54/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 33,788 ARS
- Vs Trend Line
- 4.6%
- Fair Value
- 25,445 ARS
- Vs Fair Value
- 38.9%
- 52W High
- 37,500 ARS
- 52W Low
- 18,050 ARS
- Drawdown
- -5.8%
- Range Position
- 88.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 41 weeks
- 52W Active Weeks
- 41
- 52W Active Breadth
- 78.8%
- Sector Scope
- AR Healthcare
- Sector Rank
- 17 of 20
- Sector Percentile
- 15.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AR Healthcare
- Tracked Peers
- 20
- 4W Rank
- 7 of 20
- Avg 1W
- -0.5%
- Avg 4W
- 5.2%
- Trend Breadth
- 25.0%
- Positive MD
- 20.0%
AR Drug Manufacturers - General
- Tracked Peers
- 13
- 4W Rank
- 5 of 13
- Avg 1W
- -0.6%
- Avg 4W
- 4.9%
- Trend Breadth
- 38.5%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.22
- 4W MD Change
- 79.8%
- Relative Strength
- -7.41
- 4W RS Change
- -178.0%
- Expectation
- Undecided
- Probability
- 53.77%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 5.4K
- 13W Average
- 9.2K
- 52W Average
- 18.4K
- Vs 13W
- 0.6x
- Vs 52W
- 0.3x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.0%
- 52W Volatility
- 4.9%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 5.1% / -2.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- BUE
- Country
- AR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- ARS
- Market Cap
- 8496.2B
Opportunity signals
- Trend Signal is active with a 41-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
- Latest weekly return ranks in the weaker part of its sector group.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 35,340 ARS | -3.1% | 33,788 ARS | 25,445 ARS | -0.22 | -7.41 | 5.4K | On |
| 5 Jun 2026 | 36,480 ARS | 4.0% | 33,543 ARS | 25,290 ARS | -0.41 | 4.14 | 13.3K | On |
| 29 May 2026 | 35,080 ARS | -3.5% | 33,174 ARS | 25,127 ARS | -0.68 | -1.94 | 14.6K | On |
| 22 May 2026 | 36,360 ARS | 10.0% | 32,868 ARS | 24,974 ARS | -0.88 | 13.65 | 15.8K | On |
| 15 May 2026 | 33,040 ARS | -0.1% | 32,569 ARS | 24,813 ARS | -1.11 | 9.50 | 5.8K | On |
| 8 May 2026 | 33,060 ARS | 1.0% | 32,342 ARS | 24,674 ARS | -0.96 | 7.99 | 10.7K | On |
| 1 May 2026 | 32,720 ARS | -2.2% | 32,097 ARS | 24,532 ARS | -0.83 | 5.13 | 7.4K | On |
| 24 Apr 2026 | 33,460 ARS | -3.6% | 31,912 ARS | 24,391 ARS | -0.63 | 7.56 | 12.4K | On |
| 17 Apr 2026 | 34,700 ARS | -3.0% | 31,563 ARS | 24,244 ARS | -0.52 | 10.23 | 12.4K | On |
| 10 Apr 2026 | 35,760 ARS | -0.9% | 31,253 ARS | 24,089 ARS | -0.57 | 10.18 | 6.6K | On |
| 3 Apr 2026 | 36,100 ARS | 2.1% | 30,880 ARS | 23,919 ARS | -0.53 | 11.70 | 3.3K | On |
| 27 Mar 2026 | 35,360 ARS | 5.8% | 30,459 ARS | 23,746 ARS | -0.50 | 17.82 | 5.8K | On |
| 20 Mar 2026 | 33,420 ARS | -1.7% | 30,039 ARS | 23,575 ARS | -0.03 | 14.73 | 6.3K | On |
| 13 Mar 2026 | 34,000 ARS | -0.1% | 29,699 ARS | 23,413 ARS | 0.47 | 20.88 | 11.0K | On |